Cargando…

Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality

Immune checkpoint inhibitors represent revolutionary anti-cancer agents, being rapidly approved in different malignancies and settings. Gastrointestinal (GI) cancers represent a wide variety of tumors with specific characteristics and different responses to various therapeutic alternatives; while so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kourie, Hampig Raphael, Tabchi, Samer, Ghosn, Marwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423038/ https://www.ncbi.nlm.nih.gov/pubmed/28533658 http://dx.doi.org/10.3748/wjg.v23.i17.3017

Ejemplares similares

The future of cancer research after COVID-19 pandemic: recession?
por: Kourie, Hampig Raphael, et al.
Publicado: (2020)

Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
por: Moujaess, Elissar, et al.
Publicado: (2020)

Immunotherapies in sarcoma: Updates and future perspectives
por: Ghosn, Marwan, et al.
Publicado: (2017)

Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?
por: Moujaess, Elissar, et al.
Publicado: (2020)

Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
por: Ghosn, Marwan, et al.
Publicado: (2016)

Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities
por: Elkaddoum, Ronaldo, et al.
Publicado: (2020)

The psychological challenges for oncological patients in times of COVID-19 pandemic: telemedicine, a solution?
por: Schade, Estelle Caroline, et al.
Publicado: (2020)

The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience
por: Kattan, Clarisse, et al.
Publicado: (2020)

Bioethical considerations for cancer patients care during the COVID-19 pandemic
por: Kourie, Hampig Raphael, et al.
Publicado: (2020)

The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic
por: Bitar, Nizar, et al.
Publicado: (2020)

Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature
por: Ghosn, Marwan, et al.
Publicado: (2016)

Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
por: Boutros, Marc, et al.
Publicado: (2021)

Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy
por: Kourie, Hampig Raphael, et al.
Publicado: (2015)

Charcot-Marie-Tooth hereditary neuropathy revealed after administration of docetaxel in advanced breast cancer
por: Kourie, Hampig Raphael, et al.
Publicado: (2017)

Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review
por: Simon, Aurélien, et al.
Publicado: (2017)

Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review
por: Kourie, Hampig Raphael, et al.
Publicado: (2015)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
por: Wang, Zheng-Hang, et al.
Publicado: (2018)

Unusual presentation of nasopharyngeal carcinoma with rectal metastasis
por: Vogel, Malvine, et al.
Publicado: (2017)

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
por: Tabchi, Samer, et al.
Publicado: (2017)

Triple-negative breast cancer: current perspective on the evolving therapeutic landscape
por: Mehanna, Joe, et al.
Publicado: (2019)

Vulvar Metastasis from Bladder Cancer
por: Aoun, Fouad, et al.
Publicado: (2015)

In Reply: Incorporating teleoncology practices in the undergraduate medical curriculum
por: Elkaddoum, Ronaldo, et al.
Publicado: (2020)

Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey
por: Moujaess, Elissar, et al.
Publicado: (2021)

New developments in the management of head and neck cancer – impact of pembrolizumab
por: Saleh, Khalil, et al.
Publicado: (2018)

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
por: Kourie, Hampig Raphael, et al.
Publicado: (2017)

Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa
por: Assi, Ahmad, et al.
Publicado: (2023)

GP Online: turning expectations into reality with the new NHS app
por: Beaney, Paul, et al.
Publicado: (2019)

Treating cancer patients in times of COVID-19 pandemic: A virtual women cancers multidisciplinary meeting experience
por: Elkaddoum, Ronaldo, et al.
Publicado: (2020)

A Reality Checkpoint for Mobile Health: Three Challenges to Overcome
Publicado: (2013)

Immune checkpoint inhibitors in penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2021)

Checkpoint Inhibitors in Checkmating Rare Cancers
por: Srinivas, Sujay, et al.
Publicado: (2021)

An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinib
por: Haddad, Fady Gh, et al.
Publicado: (2021)

Current Status of Immune Checkpoint Inhibitors in Gastrointestinal Cancers
por: Kim, Bum Jun, et al.
Publicado: (2017)

Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers
por: Li, Meng, et al.
Publicado: (2022)

Adenoid cystic carcinoma of the breast – an aggressive presentation with pulmonary, kidney, and brain metastases: a case report
por: Mhamdi, Hasnae Alaoui, et al.
Publicado: (2017)

Low Success Rate of ART, an Illusion, a Reality or Simply a Too High Expectation?
por: Sadeghi, Mohammad Reza
Publicado: (2012)

Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
por: Dal Collo, Giada, et al.
Publicado: (2023)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

Cardiotoxicity Associated with Immune Checkpoint Inhibitors
por: Minegishi, Shintaro, et al.
Publicado: (2023)

Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
por: Mazloom, Anita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ciue0lv74voh8s002o9h97lgk